溃疡性结肠炎
磺胺吡啶
醋酸
结肠炎
药理学
化学
炎症
医学
内科学
胃肠病学
生物化学
疾病
作者
Fares E.M. Ali,Mohamed Elfiky,Walaa A. Fadda,Howaida S. Ali,Amany Refaat Mahmoud,Zuhair M. Mohammedsaleh,Tarek Hamdy Abd-Elhamid
出处
期刊:Life Sciences
[Elsevier]
日期:2021-07-01
卷期号:276: 119433-119433
被引量:15
标识
DOI:10.1016/j.lfs.2021.119433
摘要
Ulcerative colitis (UC) is a common intestinal problem characterized by the diffusion of colon inflammation and immunity dysregulation. Nifuroxazide, a potent STAT-3 inhibitor, exhibits diverse pharmacological properties. The present study aimed to elucidate a novel anti-colitis mechanism of nifuroxazide against the acetic acid-induced UC model. Rats were grouped into control (received vehicle), UC (2 ml of 5% acetic acid by intrarectal infusion), UC plus sulfasalazine (100 mg/kg/day, P.O.), UC plus nifuroxazide (25 mg/kg/day, P.O.), and UC plus nifuroxazide (50 mg/kg/day, P.O.) and lasted for 6 days. The present study revealed that nifuroxazide significantly reduced UC measures, hematological changes, and histological alteration. In addition, treatment with nifuroxazide significantly down-regulated serum CRP as well as the colonic expressions of MPO, IL-6, TNF-α, TLR-4, NF-κB-p65, JAK1, STAT-3, DKK1 in a dose-dependent manner. Besides, our results showed that the colonic Wnt expression was up-regulated with nifuroxazide treatment. In a dose-dependent manner, nifuroxazide markedly alleviated acetic acid-induced cellular infiltration and improved ulcer healing by increasing intestinal epithelial cell regeneration. Our results collectively indicate that nifuroxazide is an effective anti-colitis agent through regulation of colon inflammation and proliferation via modulation IL-6/STAT-3/Wnt signaling pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI